|
|
|
Drug Information Association, Online
Mar 26 2008
Large and small pharmaceutical companies face an increasingly complex set of international regulations in their commitment to patient safety and Good Pharmacovigilance Practices. The specialized operational configurations of firms present complex challenges to meeting international requirements effectively. Pharmacovigilance audits can contribute to regulatory compliance and support industry best practices.
|
|
|
|
|
|
Organized by:
|
|
Drug Information Association |
|
Invited Speakers:
|
|
1) Carol L. Krueger, BSN, RNConsumer Safety Officer, Div. of Compliance Risk Management Surveillance, CDERFDAUnited States. 2) Steve T. Jolley, MAVice President, PharmacovigilancePatni Life Sciences (formerly Taratec)United States.
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
Registration:
|
|
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16807&eventType=Webinar
|
|
E-mail:
|
|
dia@diahome.org
|
|
|
|
|
|
|
|